Stocklytics Platform
Asset logo for symbol NAMS
NewAmsterdam Pharma Company N.V.
NAMS53
$24.81arrow_drop_up34.01%$6.30
High Growth
Asset logo for symbol NAMS
NAMS53

$24.81

arrow_drop_up34.01%

Performance History

Chart placeholder
Key Stats
Open$25.00
Prev. Close$18.52
EPS-2.21
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
PE Ratio-
LOWHIGH
Day Range19.33
32.34
52 Week Range5.63
32.34
Ratios
EPS-2.21

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About NewAmsterdam Pharma Company N.V. (NAMS)

NewAmsterdam Pharma Company N.V. (NAMS) is a leading pharmaceutical company in the industry, known for its innovative and high-quality products. With a rich history and a strong presence in the market, NAMS has established itself as a trusted name in the healthcare sector. The company has a diverse portfolio of drugs and therapies, catering to a wide range of medical conditions and needs.
NAMS stock price history reflects the steady growth and success of the company. Over the years, the stock has shown consistent upward trends, indicating positive investor sentiment and confidence in NAMS. The company's strong financial performance and strategic investments have played a key role in driving the stock price to new heights.
Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Michael Harvey Davidson FACC, Facc., Facp., M.D.
Headquarters
Naarden
Employees
22
Exchange
NASDAQ
add NewAmsterdam Pharma Company N.V. to watchlist

Keep an eye on NewAmsterdam Pharma Company N.V.

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is NewAmsterdam Pharma Company N.V.'s (NAMS) price per share?

The current price per share for NewAmsterdam Pharma Company N.V. (NAMS) is $24.87. The stock has seen a price change of $6.33 recently, indicating a 34.18% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for NewAmsterdam Pharma Company N.V. (NAMS)?

For NewAmsterdam Pharma Company N.V. (NAMS), the 52-week high is $32.34, which is 30.06% from the current price. The 52-week low is $5.63, the current price is 341.48% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is NewAmsterdam Pharma Company N.V. (NAMS) a growth stock?

NewAmsterdam Pharma Company N.V. (NAMS) has shown an average price growth of -2.59% over the past three years. It has received a score of 79 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying NewAmsterdam Pharma Company N.V. as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is NewAmsterdam Pharma Company N.V. (NAMS) stock price performance year to date (YTD)?

As of the latest data, NewAmsterdam Pharma Company N.V. (NAMS) has a year-to-date price change of 108.09%. Over the past month, the stock has experienced a price change of 1.13%. Over the last three months, the change has been 47.32%. Over the past six months, the figure is 26.36%.
help

Is NewAmsterdam Pharma Company N.V. (NAMS) a profitable company?

NewAmsterdam Pharma Company N.V. (NAMS) has a net income of -$176.94M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -85.89% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $12.76M, although specific revenue growth data is currently not available. The gross profit is $12.76M. Operating income is noted at -$165.73M. EBITDA information is currently not available.
help

What is the market capitalization of NewAmsterdam Pharma Company N.V. (NAMS)?

NewAmsterdam Pharma Company N.V. (NAMS) has a market capitalization of $2.29B. The average daily trading volume is 25.46, indicating the stock's liquidity and investor engagement.

Take Your Investments to a Whole New Level